February 7, 2019 News by Larry Luxner Medical Marijuana ‘Can Help Everyone,’ Says Director at Maryland Cannabis Facility Warning the reporter accompanying him not to take any pictures, veteran horticulturalist Michael Castleman punches an electronic code and unlocks the door to Room 209, nicknamed the āMother Room.ā Photography is indeed forbidden inside this living vault, which contains 20 phenotypes of cannabis plants thriving under the glare of 25…
April 12, 2018 News by Jose Marques Lopes, PhD US, Australia Issue Patents on Sonde’s Voice-analysis Technology for Diagnosing Diseases The United States and Australia have issued patents on Sonde Health‘s voice-analysis technology for diagnosing and monitoringĀ multiple sclerosisĀ and other diseases that affect speech. Sonde, which has dubbed its invention vocal biomarker technology, said the U.S. patent is Ā 9,936,914 and the Australian oneĀ 2014374349. Both patents cover Sonde’s…
April 5, 2018 News by Jose Marques Lopes, PhD 1st Patient Enrolls in Phase 3 Trial of ADS-5102 as Way of Improving Walking Ability, Adamas Announces A Phase 3 trial testing an oral once-a-day therapy ā ADS-5102 (amantadine) extended release capsules ā inĀ multiple sclerosis (MS) patients with walking difficulties has enrolled its first participant, Adamas Pharmaceuticals announced. The multi-center, double-blind study (NCT03436199) will assess ADS-5102 in about 570 such patients at five sites…
April 2, 2018 News by Diogo Pinto MS Patients Are Among the Most Satisfied with Their Healthcare, Surveys Show Multiple sclerosisĀ patients are among those with debilitating diseases who are most satisfied with their healthcare, two surveys indicate. Others who are satisfied include people withĀ amyotrophic lateral sclerosisĀ and Parkinsonās, according to the questionnaire-basedĀ PatientsLikeMeĀ research. In contrast, people with fibromyalgia, post-traumatic stress disorder (PTSD) and major depressive disorder…
February 20, 2018 News by Patricia Silva, PhD Medical Cannabis Found to Safely Reduce Chronic Pain in Older Patients in Study Medical cannabis was found to safely and significantly reduce chronic pain in older patients withĀ multiple sclerosis (MS)Ā and a wide range of other conditions, researchers in Israel report. Led by scientists at Ben-Gurion University of the Negev (BGU) and the Cannabis Clinical Research Institute at Soroka University Medical…
June 17, 2016 News by Patricia Silva, PhD Adamas Reports Positive Results in Study of Drug to Treat MS Patients with Walking Difficulties Adamas Pharmaceuticals recently reported positive results from its Phase 2 proof-of-concept clinical trial evaluating ADS-5102 (amantadine HCl), an extended-release version of amantadine, inĀ multiple sclerosis (MS) patients with difficulties inĀ walking. The trial (NCT02471222),Ā aĀ double-blind, placebo-controlled and two-arm parallel groupĀ study,Ā evaluated ADS-5102 given once dailyĀ at 340 mg, at bedtime, for four…